A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers.
As 23andMe Struggles, Concerns Surface About Its Genetic Data
A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers.
Written by
in